{"organizations": [], "uuid": "edb4ad46c5c56a86f0855960ee630d58a97860dd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/19/globe-newswire-emergent-biosolutions-to-release-first-quarter-2018-financial-results-and-conduct-a-conference-call-on-may-3-2018.html", "country": "US", "domain_rank": 767, "title": "Emergent BioSolutions to Release First Quarter 2018 Financial Results and Conduct a Conference Call on May 3, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-19T14:30:00.000+03:00", "replies_count": 0, "uuid": "edb4ad46c5c56a86f0855960ee630d58a97860dd"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/19/globe-newswire-emergent-biosolutions-to-release-first-quarter-2018-financial-results-and-conduct-a-conference-call-on-may-3-2018.html", "ord_in_thread": 0, "title": "Emergent BioSolutions to Release First Quarter 2018 Financial Results and Conduct a Conference Call on May 3, 2018", "locations": [], "entities": {"persons": [], "locations": [{"name": "md.", "sentiment": "none"}, {"name": "gaithersburg", "sentiment": "none"}], "organizations": [{"name": "emergent biosolutions inc.", "sentiment": "negative"}, {"name": "nyse", "sentiment": "negative"}, {"name": "eastern time", "sentiment": "none"}, {"name": "biosolutions emergent biosolutions inc.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "GAITHERSBURG, Md., April 19, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, May 3, 2018 at 5:00 pm (Eastern Time) to discuss the financial results for the first quarter of 2018, recent business developments, revenue guidance for the second quarter of 2018, and revenue and net income guidance for full year 2018.\nThis conference call can be accessed live by telephone or by webcast:\nLive Teleconference Information :\nDial in number: (855) 766-6521\nInternational dial in: (262) 912-6157\nConference ID: 93329114\nLive Webcast Information :\nVisit https://edge.media-server.com/m6/p/gyy8ca3t for the live webcast feed.\nA replay of the call can be accessed on Emergent’s website emergentbiosolutions.com under “ Investors .”\nAbout Emergent BioSolutions\nEmergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com . Follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.\nInvestor Contact:\nRobert G. Burrows\nVice President, Investor Relations\n240-631-3280\nBurrowsR@ebsi.com\nMedia Contact:\nLynn Kieffer\nVice President, Corporate Communications\n240-631-3391\nKiefferL@ebsi.com\nSource:Emergent BioSolutions", "external_links": ["https://www.globenewswire.com/Tracker?data=TNTAqPhCKkgnIURQfNzXbcYfGrguyk6669nklCRI2h8U_a_iKZRkGv6tqFlU9n7a-qLQij0Nd3xfbbmRuFgk31lC3y-vBagsdRhwA4sYYiQx29NsZV58PuDHRVUa-Aqe", "https://www.globenewswire.com/Tracker?data=Ll54G0L7ZJXFmcRLUTuzSFJj1FF3kZRprqoXrAza0r6jPv3LKaX8tWQxyd3s71hGyzY1xM1A88rptd71jXbFOtRWcZ4WCToVRNSU7-PHYr0YLfTdFZTKyVnwHkGlNeez", "https://www.globenewswire.com/Tracker?data=uyuiPXoc0BapRitIpdxNGuCi2Jf_ExBMg0YcoAGkU-B-TYmxb5uAA7UscgthTqnpBaKv2lEWzOLT8967MHa_leZ4mJtUr1AKZbvEf0b7lcZiSdU8kmQaMgBJJNAqonIP_8eD04VyViWz3E8XT6Vfuw==", "https://edge.media-server.com/m6/p/gyy8ca3t", "https://www.globenewswire.com/NewsRoom/AttachmentNg/5ec8a83c-1f63-4b2b-a68f-68e837b539a9", "https://www.globenewswire.com/Tracker?data=73rgbh9E-jreiVAOLeYGWZIQECzATkxJYzpSD649_xbU-WHmm8uNVH7ONgs2K1opmCKPpUr9jyN958kh0yXLs-UlxLsvzJOfzQunnSrMLJYUMgRSmZM41S7MjQx5x40jHPYtTACYBUdMWelTB0OlcVvGIyPHpamOYEtKlBfmJhA="], "published": "2018-04-19T14:30:00.000+03:00", "crawled": "2018-04-19T14:08:02.010+03:00", "highlightTitle": ""}